510(k) Report

510(k) · Cleared

Cleared

NBIL

K983134510(k) TraditionalCleared Sep 23, 199815-day reviewClass I21 CFR 862.1113

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Laboratories · MQM Bilirubin (Total And Unbound) In The Neonate Test System

Cleared on Sep 23, 1998 as substantially equivalent to K880743 (Abbott Laboratories, 1988) after a 15-day review. Its family tree reaches back 1 generation to 1988.

Decided
Sep 23, 1998
Review
15 days
Class
Class I
Product code
MQM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K880743 (1988). No later device cites it as a predicate yet.

K880743 · Abbott a-Gent Neonatal Bilirubin Reagent · Abbott Laboratories · 19881985199019952000
  1. Root · 1 generation backK880743 Abbott a-Gent Neonatal Bilirubin ReagentAbbott Laboratories · 1988
  2. This deviceK983134 NBILAbbott Laboratories · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K880743Abbott a-Gent Neonatal Bilirubin ReagentAbbott Laboratories1988—
0 (this device)K983134NBILAbbott Laboratories1998—
FIG. 1 — Lineage of K983134, 1988–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K880743Abbott a-Gent Neonatal Bilirubin Reagent
Summary page 1
…ect for any hemoglobin present in the sample. Substantial Equivalence: The Neonatal Bilirubin assay is substantially equivalent to the A-GENT® Neonatal Bilirubin assay (K880743) on the ABBOTT SPECTRUM? Series II"™ System. Neonatal Bilirubin 510(k) Section 11 September 4, 1998 Page 1 NBil_5_V1.lwp 000001…
Abbott Laboratories1988—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MQM devices

MQM Bilirubin (Total And Unbound) In The Neonate Test System: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQM

1in 2017

2008: 12011: 12014: 22017: 1
2007high 2 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQM

Too few MQM 510(k)s in any year since 2007 to give a median.

Recalls per year · MQM

No recall names MQM since 2007.

Adverse event reports per year · MQM

2in 2025

2007: 52008: 32010: 42011: 32012: 42014: 12015: 12016: 12017: 12018: 52019: 62020: 12021: 12023: 142024: 172025: 2
2007high 17 (2024) · low 0 (2009)2025

MAUDE reports naming product code MQM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—05
20081—03
20090—00
20100—04
20111—03
20120—04
20130—00
20142—01
20150—01
20160—01
20171—01
20180—05
20190—06
20200—01
20210—01
20220—00
20230—014
20240—017
20250—02
20260—0—

What is it indicated for?

The Neonatal Bilirubin assay is used for the quantitation of bilirubin in human neonate serum or plasma. Measurements of bilirubin (total and unbound) in newborn infants are used to aid in indicating the risk of bilirubin encephalopathy (kernicterus).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983134: NBIL.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K983134

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026